{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Breast cancer", "KLF2", "P21", "PIM1-PIM3 activation", "Proliferation", "UM171"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38874684", "DateCompleted": {"Year": "2024", "Month": "08", "Day": "02"}, "DateRevised": {"Year": "2024", "Month": "08", "Day": "05"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1007/s10549-024-07372-0"], "ArticleDate": [{"Year": "2024", "Month": "06", "Day": "14"}], "Journal": {"ISSN": "1573-7217", "JournalIssue": {"Volume": "207", "Issue": "2", "PubDate": {"Year": "2024", "Month": "Sep"}}, "Title": "Breast cancer research and treatment", "ISOAbbreviation": "Breast Cancer Res Treat"}, "ArticleTitle": "UM171 suppresses breast cancer progression by inducing KLF2.", "Pagination": {"StartPage": "405", "EndPage": "415", "MedlinePgn": "405-415"}, "Abstract": {"AbstractText": ["Breast cancer is the most frequent cancer in women with significant death rate. Morbidity is associated with drug resistance and metastasis. Development of novel drugs is unmet need. The aim of this study is to show potent anti-neoplastic activity of the UM171 compound on breast cancer cells and its mechanism of action.", "The inhibitory effect of UM171 on several breast cancer (BC) cell lines was examined using MTT and colony-forming assays. Cell cycle and apoptosis assays were utilized to determine the effect of UM171 on BC cell proliferation and survival. Wound healing scratch and transwell migration assays were used to examine the migration of BC cell lines in culture. Xenograft of mouse model with 4T1 cells was used to determine inhibitory effect of UM171 in vivo. Q-RT-PCR and western blotting were used to determine the expression level of genes effected by UM171. Lentivirus-mediated shRNAs were used to knockdown the expression of KLF2 in BC cells.", "UM171 was previously identified as a potent agonist of human hematopoietic stem cell renewal and inhibitor of leukemia. In this study, UM171 was shown to inhibit the growth of multiple breast cancer cell lines in culture. UM171-mediated growth inhibition was associated with the induction of apoptosis, G2/M cell cycle arrest, lower colony-forming capacity, and reduced motility. In a xenotransplantation model of mouse triple-negative breast cancer 4T1 cells injected into syngeneic BALB/c mice, UM171 strongly inhibited tumor growth at a level comparable to control paclitaxel. UM171 increased the expression of the three PIM genes (PIM1-3) in breast cancer cells. Moreover, UM171 strongly induced the expression of the tumor suppressor gene KLF2 and cell cycle inhibitor P21<sup>CIP1</sup>. Accordingly, knockdown of KLF2 using lentivirus-mediated shRNA significantly attenuated the growth suppressor activity of UM171. As PIM1-3 act as oncogenes and are involved in breast cancer progression, induction of these kinases likely impedes the inhibitory effect of KLF2 induction by UM171. Accordingly, combination of UM171 with a PAN-PIM inhibitor LGH447 significantly reduced tumor growth in culture.", "These results suggested that UM171 inhibited breast cancer progression in part through activation of KLF2 and P21. Combination of UM171 with a PAN-PIM inhibitor offer a novel therapy for aggressive forms of breast cancer."], "CopyrightInformation": "\u00a9 2024. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guizhou University of Traditional Chinese Medicine, Guiyang, China."}], "LastName": "Ran", "ForeName": "Xiaojuan", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, Guizhou, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Natural Products Research Center of Guizhou Province, Guiyang, Guizhou, People's Republic of China."}], "LastName": "Hu", "ForeName": "Anling", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, Guizhou, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Natural Products Research Center of Guizhou Province, Guiyang, Guizhou, People's Republic of China."}], "LastName": "Kuang", "ForeName": "Yi", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, Guizhou, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Natural Products Research Center of Guizhou Province, Guiyang, Guizhou, People's Republic of China."}], "LastName": "Wang", "ForeName": "Chunlin", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, Guizhou, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Natural Products Research Center of Guizhou Province, Guiyang, Guizhou, People's Republic of China."}], "LastName": "Liu", "ForeName": "Wuling", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, Guizhou, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Natural Products Research Center of Guizhou Province, Guiyang, Guizhou, People's Republic of China."}], "LastName": "Xiao", "ForeName": "Xiao", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, Laboratory Medicine & Pathobiology and Medical Biophysics, University of Toronto, Toronto, ON, M5G 1L1, Canada."}, {"Identifier": [], "Affiliation": "Division of Advanced Diagnostics, Toronto General Research Institute, University Health Network, Toronto, ON, Canada."}], "LastName": "Zacksenhaus", "ForeName": "Eldad", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guizhou University of Traditional Chinese Medicine, Guiyang, China. Xiangdi_Yu@163.com."}, {"Identifier": [], "Affiliation": "Anesthesiology Department of Liuzhou People's Hospital affiliated to Guangxi Medical University, Liuzhou, 545000, Guangxi, China. Xiangdi_Yu@163.com."}], "LastName": "Yu", "ForeName": "Xiangdi", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, Guizhou, People's Republic of China. yaacovbendavid@hotmail.com."}, {"Identifier": [], "Affiliation": "The Natural Products Research Center of Guizhou Province, Guiyang, Guizhou, People's Republic of China. yaacovbendavid@hotmail.com."}], "LastName": "Ben-David", "ForeName": "Yaacov", "Initials": "Y"}], "GrantList": [{"GrantID": "(QKHJC-ZK[2024] Yiban 641)", "Agency": "the Science and Technology Department of Guizhou Province", "Country": ""}, {"GrantID": "(QZYY-2024-023)", "Agency": "the Guizhou Administration of Traditional Chinese Medicine", "Country": ""}, {"GrantID": "QKHJC-ZK[2023]YB240", "Agency": "the Science and Technology Department of Guizhou Province Grants", "Country": ""}, {"GrantID": "QKHJC-ZK [2022]YB297", "Agency": "the Science and Technology Department of Guizhou Province Grants", "Country": ""}, {"GrantID": "QJHKYZ [2022]391", "Agency": "the Open Grant from State Key Laboratory for Functions and Applications of Medicinal Plants of Guizhou Medical University", "Country": ""}, {"GrantID": "82060239", "Agency": "the National Natural Science Foundation of China", "Country": ""}, {"GrantID": "U1812403", "Agency": "the National Natural Science Foundation of China", "Country": ""}, {"GrantID": "Qiankehejichu-ZK [2021] Zhongdian006", "Agency": "Guizhou Provincial Natural Science Foundation of China", "Country": ""}, {"GrantID": "GZSYQCC [2016]001", "Agency": "Guizhou Provincial High level creative talents cultivation plan: Thousand plan", "Country": ""}, {"GrantID": "B2023047", "Agency": "Guangzhou Provincial Medical Science Basic Research", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Breast Cancer Res Treat", "NlmUniqueID": "8111104", "ISSNLinking": "0167-6806"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Kruppel-Like Transcription Factors"}, {"RegistryNumber": "0", "NameOfSubstance": "KLF2 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["metabolism", "genetics"], "DescriptorName": "Kruppel-Like Transcription Factors"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["pathology", "metabolism", "genetics", "drug therapy"], "DescriptorName": "Breast Neoplasms"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Xenograft Model Antitumor Assays"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Movement"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Disease Progression"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}], "CoiStatement": "The authors have declared that no competing interest exists."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Phi LTH, Sari IN, Yang YG, Lee SH, Jun N, Kim KS, Lee YK, Kwon HY (2018) Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment. Stem Cells Int. 10.1155/2018/5416923 10.1155/2018/5416923", "ArticleIdList": ["10.1155/2018/5416923", "PMC5850899", "29681949"]}, {"Citation": "Sampieri K, Fodde R (2012) Cancer stem cells and metastasis. Semin Cancer Biol 22(3):187\u2013193. 10.1016/j.semcancer.2012.03.002 10.1016/j.semcancer.2012.03.002", "ArticleIdList": ["10.1016/j.semcancer.2012.03.002", "22774232"]}, {"Citation": "Fares I, Chagraoui J, Gareau Y, Gingras S, Ruel R, Mayotte N, Csaszar E, Knapp DJ, Miller P, Ngom M, Imren S, Roy DC, Watts KL, Kiem HP, Herrington R, Iscove NN, Humphries RK, Eaves CJ, Cohen S, Marinier A, Zandstra PW, Sauvageau G (2014) Cord blood expansion. Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal. Science 345(6203):1509\u20131512. 10.1126/science.1256337 10.1126/science.1256337", "ArticleIdList": ["10.1126/science.1256337", "PMC4372335", "25237102"]}, {"Citation": "Cohen S, Roy J, Lachance S, Delisle JS, Marinier A, Busque L, Roy DC, Barab\u00e9 F, Ahmad I, Bambace N, Bernard L, Kiss T, Bouchard P, Caudrelier P, Landais S, Larochelle F, Chagraoui J, Lehnertz B, Corneau S, Tomellini E, van Kampen JJA, Cornelissen JJ, Dumont-Lagac\u00e9 M, Tanguay M, Li Q, Lemieux S, Zandstra PW, Sauvageau G (2020) Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1\u20132 safety and feasibility study. Lancet Haematol 7(2):e134\u2013e145. 10.1016/s2352-3026(19)30202-9 10.1016/s2352-3026(19)30202-9", "ArticleIdList": ["10.1016/s2352-3026(19)30202-9", "31704264"]}, {"Citation": "Fares I, Chagraoui J, Lehnertz B, MacRae T, Mayotte N, Tomellini E, Aubert L, Roux PP, Sauvageau G (2017) EPCR expression marks UM171-expanded CD34(+) cord blood stem cells. Blood 129(25):3344\u20133351. 10.1182/blood-2016-11-750729 10.1182/blood-2016-11-750729", "ArticleIdList": ["10.1182/blood-2016-11-750729", "28408459"]}, {"Citation": "Subramaniam A, \u017demaitis K, Talkhoncheh MS, Yudovich D, B\u00e4ckstr\u00f6m A, Debnath S, Chen J, Jain MV, Galeev R, Gaetani M, Zubarev RA, Larsson J (2020) Lysine-specific demethylase 1A restricts ex vivo propagation of human HSCs and is a target of UM171. Blood 136(19):2151\u20132161. 10.1182/blood.2020005827 10.1182/blood.2020005827", "ArticleIdList": ["10.1182/blood.2020005827", "PMC7645986", "32582923"]}, {"Citation": "Chagraoui J, Girard S, Spinella JF, Simon L, Bonneil E, Mayotte N, MacRae T, Coulombe-Huntington J, Bertomeu T, Moison C, Tomellini E, Thibault P, Tyers M, Marinier A, Sauvageau G (2021) UM171 preserves epigenetic marks that are reduced in ex vivo culture of human HSCs via potentiation of the CLR3-KBTBD4 complex. Cell Stem Cell 28(1):48\u201362. 10.1016/j.stem.2020.12.002 10.1016/j.stem.2020.12.002", "ArticleIdList": ["10.1016/j.stem.2020.12.002", "33417871"]}, {"Citation": "Hu A, Gao J, Varier KM, Gajendran B, Jiang F, Liu W, Wang C, Xiao X, Li Y, Zacksenhaus E, Ali S, Ben-David Y (2022) UM171 cooperates with PIM1 inhibitors to restrict HSC expansion markers and suppress leukemia progression. Cell Death Discov 8(1):448. 10.1038/s41420-022-01244-6 10.1038/s41420-022-01244-6", "ArticleIdList": ["10.1038/s41420-022-01244-6", "PMC9637110", "36335089"]}, {"Citation": "Wang JC, Dick JE (2005) Cancer stem cells: lessons from leukemia. Trends Cell Biol 15(9):494\u2013501. 10.1016/j.tcb.2005.07.004 10.1016/j.tcb.2005.07.004", "ArticleIdList": ["10.1016/j.tcb.2005.07.004", "16084092"]}, {"Citation": "Agboyibor C, Dong J, Effah CY, Drokow EK, Pervaiz W, Liu HM (2021) LSD1 as a biomarker and the outcome of its inhibitors in the clinical trial: the therapy opportunity in tumor. J Oncol. 10.1155/2021/5512524 10.1155/2021/5512524", "ArticleIdList": ["10.1155/2021/5512524", "PMC8018836", "33833800"]}, {"Citation": "Ravasio R, Ceccacci E, Nicosia L, Hosseini A, Rossi PL, Barozzi I, Fornasari L, Zuffo RD, Valente S, Fioravanti R, Mercurio C, Varasi M, Mattevi A, Mai A, Pavesi G, Bonaldi T, Minucci S (2020) Targeting the scaffolding role of LSD1 (KDM1A) poises acute myeloid leukemia cells for retinoic acid-induced differentiation. Sci Adv 6(15):2746. 10.1126/sciadv.aax274610.1126/sciadv.aax2746", "ArticleIdList": ["10.1126/sciadv.aax2746", "PMC7141832", "32284990"]}, {"Citation": "Wu N, Chen S, Luo Q, Jiang Z, Wang X, Li Y, Qiu J, Yu K, Yang Y, Zhuang J (2022) Kruppel-like factor 2 acts as a tumor suppressor in human retinoblastoma. Exp Eye Res 216:108955. 10.1016/j.exer.2022.108955 10.1016/j.exer.2022.108955", "ArticleIdList": ["10.1016/j.exer.2022.108955", "35074341"]}, {"Citation": "Li J, Jiang JL, Chen YM, Lu WQ (2023) KLF2 inhibits colorectal cancer progression and metastasis by inducing ferroptosis via the PI3K/AKT signaling pathway. J Pathol Clin Res 9(5):423\u2013435. 10.1002/cjp2.325 10.1002/cjp2.325", "ArticleIdList": ["10.1002/cjp2.325", "PMC10397377", "37147883"]}, {"Citation": "Li XM, Hu SJ, Liu JF, Ma MJ, Du LM, Bai FH (2023) Kr\u00fcppel-like factor 2 is a gastric cancer suppressor and prognostic biomarker. Evid-Based Complement Altern Med: eCAM. 10.1155/2023/236014910.1155/2023/2360149", "ArticleIdList": ["10.1155/2023/2360149", "PMC9981288", "36874616"]}, {"Citation": "Liu CY, Chang TH, Hsieh CH, Chang YH, Pang JS, Chuang CK (2022) Kruppel-like factor 2 inhibits proliferation in renal angiomyolipoma via IL-6/JAK/STAT3 signaling pathway. Anticancer Res 42(10):4753\u20134762. 10.2187/anticanres.15980 10.2187/anticanres.15980", "ArticleIdList": ["10.2187/anticanres.15980", "36191984"]}, {"Citation": "Gao J, Hu J, Yu F, Wang C, Sheng D, Liu W, Hu A, Yu K, Xiao X, Kuang Y, Zacksenhaus E, Gajendran B, Ben-David Y (2023) Lovastatin inhibits erythroleukemia progression through KLF2-mediated suppression of MAPK/ERK signaling. BMC Cancer 23(1):306. 10.1186/s12885-023-10742-4 10.1186/s12885-023-10742-4", "ArticleIdList": ["10.1186/s12885-023-10742-4", "PMC10071686", "37016335"]}, {"Citation": "Zhu KY, Tian Y, Li YX, Meng QX, Ge J, Cao XC, Zhang T, Yu Y (2022) The functions and prognostic value of Kr\u00fcppel-like factors in breast cancer. Cancer Cell Int 22(1):23. 10.1186/s12935-022-02449-6 10.1186/s12935-022-02449-6", "ArticleIdList": ["10.1186/s12935-022-02449-6", "PMC8760734", "35033064"]}, {"Citation": "Wang C, Sample KM, Gajendran B, Kapranov P, Liu W, Hu A, Zacksenhaus E, Li Y, Hao X, Ben-David Y (2021) FLI1 induces megakaryopoiesis gene expression through WAS/WIP-dependent and independent mechanisms; implications for wiskott-aldrich syndrome. Front Immunol 12:607836. 10.3389/fimmu.2021.607836 10.3389/fimmu.2021.607836", "ArticleIdList": ["10.3389/fimmu.2021.607836", "PMC7953068", "33717090"]}, {"Citation": "Crown J, O\u2019Leary M, Ooi WS (2004) Docetaxel and paclitaxel in the treatment of breast cancer: a review of clinical experience. Oncologist 9(2):24\u201332. 10.1634/theoncologist.9-suppl_2-24 10.1634/theoncologist.9-suppl_2-24", "ArticleIdList": ["10.1634/theoncologist.9-suppl_2-24", "15161988"]}, {"Citation": "Kunder R, Velyunskiy M, Dunne SF, Cho BK, Kanojia D, Begg L, Orriols AM, Fleming-Trujillo E, Vadlamani P, Vialichka A, Bolin R, Perrino JN, Roth D, Clutter MR, Zielinski-Mozny NA, Goo YA, Cristofanilli M, Mendillo ML, Vassilopoulos A, Horiuchi D (2022) Synergistic PIM kinase and proteasome inhibition as a therapeutic strategy for MYC-overexpressing triple-negative breast cancer. Cell Chem Biol 29(3):358\u2013372. 10.1016/j.chembiol.2021.08.011 10.1016/j.chembiol.2021.08.011", "ArticleIdList": ["10.1016/j.chembiol.2021.08.011", "PMC8901784", "34525344"]}, {"Citation": "Landor SKJ, Santio NM, Eccleshall WB, Paramonov VM, Gagliani EK, Hall D, Jin SB, Dahlstr\u00f6m KM, Salminen TA, Rivero-M\u00fcller A, Lendahl U, Kovall RA, Koskinen PJ, Sahlgren C (2021) PIM-induced phosphorylation of Notch3 promotes breast cancer tumorigenicity in a CSL-independent fashion. J Biol Chem 296:100593. 10.1016/j.jbc.2021.100593 10.1016/j.jbc.2021.100593", "ArticleIdList": ["10.1016/j.jbc.2021.100593", "PMC8100066", "33775697"]}, {"Citation": "Zhao W, Qiu R, Li P, Yang J (2017) PIM1: a promising target in patients with triple-negative breast cancer. Med Oncol 34(8):142. 10.1007/s12032-017-0998-y 10.1007/s12032-017-0998-y", "ArticleIdList": ["10.1007/s12032-017-0998-y", "28721678"]}, {"Citation": "Sawaguchi Y, Yamazaki R, Nishiyama Y, Mae M, Abe A, Nishiyama H, Nishisaka F, Ibuki T, Sasai T, Matsuzaki T (2021) Novel pan-pim kinase inhibitors with imidazopyridazine and thiazolidinedione structure exert potent antitumor activities. Front Pharmacol 12:672536. 10.3389/fphar.2021.672536 10.3389/fphar.2021.672536", "ArticleIdList": ["10.3389/fphar.2021.672536", "PMC8126654", "34012401"]}, {"Citation": "Rajan AM, Kumar S (2016) New investigational drugs with single-agent activity in multiple myeloma. Blood Cancer J 6(7):e451. 10.1038/bcj.2016.53 10.1038/bcj.2016.53", "ArticleIdList": ["10.1038/bcj.2016.53", "PMC5030378", "27471867"]}, {"Citation": "Bras\u00f3-Maristany F, Filosto S, Catchpole S, Marlow R, Quist J, Francesch-Domenech E, Plumb DA, Zakka L, Gazinska P, Liccardi G, Meier P, Gris-Oliver A, Cheang MC, Perdrix-Rosell A, Shafat M, No\u00ebl E, Patel N, McEachern K, Scaltriti M, Castel P, Noor F, Buus R, Mathew S, Watkins J, Serra V, Marra P, Grigoriadis A, Tutt AN (2016) PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer. Nat Med 22(11):1303\u20131313. 10.1038/nm.4198 10.1038/nm.4198", "ArticleIdList": ["10.1038/nm.4198", "PMC5552044", "27775704"]}, {"Citation": "Mung KL, Eccleshall WB, Santio NM, Rivero-M\u00fcller A, Koskinen PJ (2021) PIM kinases inhibit AMPK activation and promote tumorigenicity by phosphorylating LKB1. Cell Commun Signal: CCS 19(1):68. 10.1186/s12964-021-00749-4 10.1186/s12964-021-00749-4", "ArticleIdList": ["10.1186/s12964-021-00749-4", "PMC8247201", "34193159"]}, {"Citation": "Wang B, Liu M, Song Y, Li C, Zhang S, Ma L (2019) KLF2 inhibits the migration and invasion of prostate cancer cells by downregulating MMP2. Am J Men\u2019s Health 13(1):1557988318816907. 10.1177/1557988318816907 10.1177/1557988318816907", "ArticleIdList": ["10.1177/1557988318816907", "PMC6775556", "30520325"]}, {"Citation": "Shamloo B, Usluer S (2019) p21 in Cancer research. Cancers. 10.3390/cancers11081178 10.3390/cancers11081178", "ArticleIdList": ["10.3390/cancers11081178", "PMC6721478", "31416295"]}, {"Citation": "Yu ZH, Chen ZH, Zhou GL, Zhou XJ, Ma HY, Yu Y, Wang X, Cao XC (2022) miR-92a-3p promotes breast cancer proliferation by regulating the KLF2/BIRC5 axis. Thorac Cancer 13(21):2992\u20133000. 10.1111/1759-7714.14648 10.1111/1759-7714.14648", "ArticleIdList": ["10.1111/1759-7714.14648", "PMC9626348", "36100919"]}]}], "History": [{"Year": "2024", "Month": "2", "Day": "7"}, {"Year": "2024", "Month": "5", "Day": "9"}, {"Year": "2024", "Month": "8", "Day": "2", "Hour": "12", "Minute": "41"}, {"Year": "2024", "Month": "6", "Day": "14", "Hour": "12", "Minute": "44"}, {"Year": "2024", "Month": "6", "Day": "14", "Hour": "11", "Minute": "6"}, {"Year": "2024", "Month": "6", "Day": "14"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38874684", "PMC11297059", "10.1007/s10549-024-07372-0", "10.1007/s10549-024-07372-0"]}}]}